J Neurol Surg A Cent Eur Neurosurg
DOI: 10.1055/a-2590-6108
Original Article

Middle Meningeal Artery Embolization for Acute Epidural Hematomas: A Promising Alternative to Traditional Surgery

Authors

  • Artem Stanishevskiy

    1   Department of Neurosurgery, Military Medical Academy named after S M Kirov of the Ministry of Defense of the Russian Federation, Saint Petersburg, Russia
  • Konstantin Babichev

    1   Department of Neurosurgery, Military Medical Academy named after S M Kirov of the Ministry of Defense of the Russian Federation, Saint Petersburg, Russia
  • Arevik Abramyan

    2   Department of Neurosurgery, Rutgers the State University of New Jersey, New Brunswick, New Jersey, United States
  • Dmitriy Svistov

    1   Department of Neurosurgery, Military Medical Academy named after S M Kirov of the Ministry of Defense of the Russian Federation, Saint Petersburg, Russia
  • Alexander Savello

    1   Department of Neurosurgery, Military Medical Academy named after S M Kirov of the Ministry of Defense of the Russian Federation, Saint Petersburg, Russia
  • Roman Martynov

    1   Department of Neurosurgery, Military Medical Academy named after S M Kirov of the Ministry of Defense of the Russian Federation, Saint Petersburg, Russia
  • Djamalud Isaev

    1   Department of Neurosurgery, Military Medical Academy named after S M Kirov of the Ministry of Defense of the Russian Federation, Saint Petersburg, Russia

Funding None.

Abstract

Background

Acute epidural hematoma (AEDH) is recognized as one of the most urgent neurosurgical conditions. Traditionally, the primary treatment for AEDH has involved craniotomy with surgical evacuation of the hematoma. However, with the widespread adoption of neurointerventional techniques, interest in their application to various forms of traumatic brain injuries has increased. Among these, embolization of the middle meningeal artery (MMA) has emerged as a minimally invasive treatment option for AEDH. This study evaluates the effectiveness of MMA embolization as a primary treatment for AEDH.

Methods

We conducted a retrospective review of patients treated for AEDH with embolization of the MMA at our institution from January 2019 to July 2024. Patient demographics, clinical presentation, procedural details, and outcomes were analyzed.

Results

MMA embolization was successfully performed in 20 patients with AEDH, with only 2 cases requiring subsequent burr-hole evacuation. The thickness of the AEDH was 10 mm or more in 47.8% of cases, and a midline shift was observed in 65.2% of cases. The most common angiographic findings included arteriovenous fistulas (AVFs) and contrast extravasation. N-butyl cyanoacrylate was used as the embolic material in all cases. In one case, Squid 12 was added to enhance penetration at sites of extravasation. No patients experienced recurrent AEDH postintervention.

Conclusion

MMA embolization is a promising minimally invasive treatment for AEDH, showing effectiveness as both a primary and adjuvant therapy. Future prospective multicenter studies are needed to validate preliminary findings and optimize treatment protocols for this high-risk patient population.

Ethical Approval

The institutional review board approved the study design with a waiver of informed consent due to its retrospective nature.


Authors' Contributions

A.S.: Conceptualization, data curation, methodology, writing—original draft


K.B.: Conceptualization, data curation


A.A.: Conceptualization, writing—review and editing


D.S.: Supervision


A.S.: Supervision


R.M.: Data curation


D.I.: Data curation




Publication History

Received: 12 September 2024

Accepted: 16 April 2025

Accepted Manuscript online:
17 April 2025

Article published online:
18 November 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany